Atlas Venture-backed biotech Kymera heads to clinic after $100M round

After years of forecasting it would start its first in-human testing in 2020, a biotech startup founded by Atlas Venture is ready to go.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.